InvestorsHub Logo
Followers 12
Posts 1139
Boards Moderated 0
Alias Born 02/13/2018

Re: Latane post# 103531

Sunday, 08/09/2020 8:49:27 AM

Sunday, August 09, 2020 8:49:27 AM

Post# of 232526
Exactly. It’s really odd how little information or acknowledgement of trial progression is out in the public domain. The fact other therapies are still discussed even after failing to meet primary endpoints is malpractice. However, leronlimab will have a real breakout opportunity this week. We’ll see if it’s Cinderella or falls back into the heap
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News